Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results
July 01, 2020 17:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 01, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading global point-of-care diagnostic company focused on infectious diseases, today announced today...
Chembio Diagnostics Receives FDA 510(k) Clearance for DPP Zika IgM System
June 08, 2020 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., June 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has...
Chembio Diagnostics Strengthens Commercial Organization
June 02, 2020 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., June 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that Chuck...
Chembio Diagnostics to Participate in Upcoming Investor Conferences
May 26, 2020 16:15 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 26, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the company...
Chembio Diagnostics Announces US Distribution Agreement to Expand Reach of DPP COVID-19 Serological Test with Thermo Fisher Scientific’s Healthcare Channel
May 18, 2020 07:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 18, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has signed a...
Chembio Diagnostics Announces Closing of Public Offering of Common Stock
May 11, 2020 10:20 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the...
Chembio Diagnostics Announces Pricing of Public Offering of Common Stock
May 07, 2020 08:55 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 07, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the...
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
May 06, 2020 16:01 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today a...
Chembio Diagnostics Reports First Quarter 2020 Financial Results
May 04, 2020 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics Attains CE Marking for DPP COVID-19 System for IgG and IgM Antibodies
May 04, 2020 16:04 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has attained...